Rapid sales growth prompts need for capacity expansion Danish based HAMLET PROTEIN has commenced a multi-million dollar investment in a new US sales and production company on the back of strong sales growth in the North American market. Employing an initial 25 members of staff, the US organisation will be responsible for serving customers in the entire NAFTA region.
Unique technology Located in Findlay, Ohio, the new production plant is expected to go into operation in early 2012, combining HAMLET PROTEIN’s unique bio-based technology with raw materials supplied by the area’s large soya-farming community. The bioconversion technology from HAMLET PROTEIN is based on minimum energy consumption, no use of chemicals in the manufacturing process and a minimum of waste.
Prepared for growing demands The significant expansion of overall production capacity is consistent with HAMLET PROTEIN’s global expansion strategy and will equip the company to meet growing market demand for its speciality soya proteins for animal feed.
The US Mid-West is the perfect location for this expansion, offering easy access to raw materials and an established customer base. “So far we have focused mainly on piglet feed, and we have experienced a high level of acceptance of our proteins in North America. With the trend we see in the market, we are confident that our timing is right,” says Chief Executive Officer, Søren Munch. “Through our new sales and production organisation, we will be able to provide a much improved service to customers in the NAFTA region,” Munch continues.